E
Elevance Health, Inc. (ELV)
NYQ – Real Time Price. Currency in USD
286.39
-7.86 (-2.67%)
At close: Mar 27, 2026, 4:00 PM EDT
286.00
-0.39 (-0.14%)
After-hours: Mar 27, 2026, 7:46 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
286.39
-7.86 (-2.67%)
At close: Mar 27, 2026, 4:00 PM EDT
286.00
-0.39 (-0.14%)
After-hours: Mar 27, 2026, 7:46 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.54 | 2.52 | 8.0 | |
| Quick ratio | N/A | 2.36 | 1.0 | |
| Debt to Equity | 0.75 | 0.46 | 7.0 | |
| Debt to Assets | 0.27 | 0.44 | 7.0 | |
| Interest coverage | N/A | 67.62 | 10 | |
| Weighted average score | 6.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 156.59B | 171.34B | 176.81B | 199.13B | 199.13B |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | 8.45B | 8.74B | 8.89B | 8.11B | 8.11B |
| Net Income | 5.89B | 5.99B | 5.98B | 5.66B | 5.66B |
| EBITDA | N/A | N/A | N/A | N/A | N/A |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -1.2 | -10.31 | 1.0 |
| Next quarter | -2.95 | -26.97 | 1.0 |
| Current year | -2.35 | -14.63 | 1.0 |
| Next year | 2.12 | 12.28 | 5.0 |
| Weighted average score | 2.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -1.89 | -53.98 | -44.77 | -126.96 | 1.0 |
| Y/Y | 9.47 | 30.86 | -13.27 | -154.42 | 4.5 |
| 3y average | 8.41 | -1.27 | 1.8 | -23.19 | 2.8 |
| 5y average | 10.39 | 5.25 | 6.57 | -18.93 | 4.5 |
| Weighted average score | 3.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 2.12 | 2.12 | 7.0 |
| Payout ratio | 21.46 | 21.46 | 4.0 |
| 5-year dividend growth rate | 12.47 | 12.47 | 10 |
| Years of dividend increase | 14.00 | 14.00 | 8.0 |
| Weighted average score | 7.3 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 7.0 |
| Intangible assets | Medium | 6.0 |
| Switching costs | Medium | 7.0 |
| Network effect | Narrow | 3.0 |
| Economies of scale | Medium | 7.0 |
| Weighted average score | 6.0 | |
Total debt $32.7B significantly exceeds cash reserves ($9.5B), raising financial stability concerns
Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.7) is well below the industry average (0.5), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
Negative free cash flow -$209.0M limits the company's ability to reinvest or pay down debt